Table 3.

Multivariate analysis for overall survival (OS).

Variable	HR (95% CI)	p value
Gender		0.527
Male	1
Female	0.86 (0.53–1.39)
Stage		0.151
III	1
IV	1.70 (0.70–3.53)
Type of immunotherapy		0.016
Anti-PD1	0.56 (0.35–0.89)
Anti-PD-L1	1
Type of cancer		0.002
Lung cancer	1
Renal cancer	0.36 (0.19–0.65)
Bladder cancer	0.77 (0.43–1.37)
Ovarian cancer	0.45 (0.16–1.24)
Other	0.29 (0.12–0.69)
Endocrine complication		0.018
No	1
Yes	0.53 (0.32–0.90)
ECOG-PS		0.877
0–1	1
≥2	0.96 (0.55–1.66)